Lupin unveils Glucagon for Injection for severe hypoglycemia in patients with diabetes mellitus in US Ruchika Sharma11 Aug 2025 12:44 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Glucagon for Injection USP, 1mg/vial packaged in an emergency kit in the...
Low Blood Sugar Before Pregnancy May Raise Risk of Preterm Birth, Low Birth Weight: Study Finds Dr. Bhumika Maikhuri31 July 2025 8:15 AM ISTWomen with low blood sugar levels before conception may face an increased risk of adverse pregnancy outcomes, according to a new study published in...
Once-Weekly Semaglutide-Insulin Combo Matches Daily Basal-Bolus in Type 2 Diabetes Control: Study Dr Riya Dave25 July 2025 9:30 AM ISTAccording to a Phase 3 trial published in The Lancet Diabetes & Endocrinology, a once-weekly combination of semaglutide and insulin icodec was...
Lupin wins USFDA nods for Liraglutide, Glucagon Injectable Products Ruchika Sharma24 July 2025 11:14 AM ISTMumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated...
Medical Bulletin 14/Jul/2025 Dr. Bhumika Maikhuri14 July 2025 3:00 PM ISTHere are the top medical news for the day:Gabapentin Tied to 85% Higher Risk of Cognitive Impairment: Study FindsRegular use of the drug gabapentin...
New Wireless Skin Implant Could Prevent Hypoglycemia in Type 1 Diabetics: Study Shows Dr. Bhumika Maikhuri14 July 2025 8:30 AM ISTA new study published in Nature Biomedical Engineering reveals a potentially life-saving innovation for people with Type 1 diabetes: an implantable...
Once-Weekly Insulin Efsitora Matches Daily Insulin in Type 2 Diabetes Management: NEJM Dr Riya Dave3 July 2025 9:00 AM ISTIn the QWINT-1 phase III trial, once-weekly insulin efsitora demonstrated non-inferior efficacy and safety compared to once-daily insulin glargine...
Continuous exercise may immediately lower glucose levels regardless of Menstrual Cycle Phase, finds study Dr Riya Dave21 Jun 2025 9:30 AM ISTResearchers have found in a new study Continuous exercise (CONT) immediately lowers glucose levels regardless of the menstrual phase. However, time in...
Low Income Tied to Higher Risk of Severe Hypoglycemia in Type 2 Diabetes, Study Finds Medha Baranwal17 Jun 2025 9:15 AM ISTSouth Korea: A large-scale cohort study published in JAMA Network Open highlights a strong connection between income levels and the risk of severe...
Hypoglycemia may contributes to eye damage and vision loss in diabetic retinopathy; experimental drug may help treat condition: Study Dr. Kamal Kant Kohli8 May 2025 8:00 AM ISTIn a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have...
AID beneficial and safe option for improving HbA1C among insulin-dependent type 2 diabetes patients: JAMA Dr Riya Dave20 Feb 2025 8:30 AM ISTA nonrandomized clinical trial found that HbA1c levels decreased in a diverse group of adults with type 2 diabetes after starting automated insulin...
Sanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management Farhat Nasim17 Feb 2025 7:56 PM ISTNew Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin...
